Research looks at GIP's role in glycemic control

11/28/2011 |

A study in Diabetes of 10 healthy adult males revealed that glucose-dependent insulinotropic polypeptide infusion boosts glucagon responses during hypoglycemia and euglycemia, without affecting insulin secretion. Experts also found that GIP increases insulin secretion during hyperglycemia by more than twofold, but did not appear to affect glucagon response.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT